Clinical Trial Detail

NCT ID NCT02501902
Title Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

pancreatic ductal adenocarcinoma

Therapies

Nab-paclitaxel + Palbociclib

Age Groups: adult

No variant requirements are available.